Takuya Hashimoto, Yasuhiko Sugawara, Yoji Kishi, Nobuhisa Akamatsu, Yuichi Matsui, Norihiro Kokudo, Masatoshi Makuuchi – 17 February 2005 – A right lateral sector graft (RLSG) was devised to overcome graft‐size disparity in living donor liver transplantation (LDLT). When the RLSG has a middle hepatic vein (MHV) tributary, which drains a significant part of segment VI, the MHV tributary (V6) should be reconstructed to avoid congestion of the RLSG.

Roy Y. Calne – 17 February 2005

John Fung, Dympna Kelly, Zakiyah Kadry, Kusum Patel‐Tom, Bijan Eghtesad – 17 February 2005 – Although calcineurin inhibitors (CNIs) remain the mainstay of immunosuppression in liver transplantation (LTX), their long‐term toxicity significantly contributes to morbidity and mortality. The elucidation of mechanisms of alloimmunity and leukocyte migration have provided novel targets for immunosuppression development. The toxicities of these agents differ from that of the CNI and act additively or synergistically.

Russell H. Wiesner – 17 February 2005

Mark W. Russo, Roshan Shrestha – 21 January 2005

Paolo R.O. Salvalaggio, Alan J. Koffron, Jonathan P. Fryer, Michael M. Abecassis – 21 January 2005 – Transjugular intrahepatic shunts (TIPSs) are widely used in the management of portal hypertension complications including variceal bleeding, refractory ascites, and hepatic hydrothorax. Vena cava filters (VCFs) are an important therapeutic modality in the prevention of pulmonary emboli in patients suffering deep venous thrombosis and clinical contraindications for anticoagulation. Stent and filter misplacement or migration may occur, complicating liver transplantation (LT) surgery.

Kazuo Chin, Shinji Uemoto, Ken‐ichi Takahashi, Hiroto Egawa, Mureo Kasahara, Yasuhiro Fujimoto, Kensuke Sumi, Michiaki Mishima, Colin E. Sullivan, Kouichi Tanaka – 21 January 2005 – Pulmonary complications are an important cause of the mortality associated with liver transplantation. The efficacy of noninvasive ventilation (NIV) in pediatric patients following transplantation is unknown. The purpose of this retrospective study is to investigate the effects of NIV for pediatric patients undergoing liver transplantation.

Jai Young Cho, Kyung‐Suk Suh, Choon Hyuck Kwon, Nam‐Joon Yi, Soo Youn Cho, Ja‐June Jang, Se Hyung Kim, Kuhn Uk Lee – 21 January 2005 – The aim of this study was to assess histologic changes in steatotic grafts, regenerative capacity, and the outcome of steatotic grafts in living‐donor liver transplantation (LDLT). Between September 2002 and February 2004, 55 cases of LDLT with a liver biopsy performed on the 10th postoperative day were enrolled.

Michael G. Dulitz, Andre M. De Wolf, Hak Wong, Chris Wray, Saadia Sherwani, Josh Herborn, Robert L. Sufit, Alan J. Koffron – 21 January 2005 – We present a case of brachial plexus injury in a living‐related liver donor, most likely caused by compression of the plexus between the 1st rib and clavicle, the result of rib retraction for surgical exposure. (Liver Transpl 2005;11:233–235.)

Brian D. Shames, Luis A. Fernandez, Hans W. Sollinger, L. Thomas Chin, Anthony M. D'Alessandro, Stuart J. Knechtle, Michael R. Lucey, Reza Hafez, Alexandru I. Musat, Munci Kalayoglu – 21 January 2005 – Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome is a rare complication of pregnancy that is associated with preeclampsia and may result in rupture of the liver. Although there have been case reports of liver transplantation for HELLP syndrome, the outcomes of transplantation for this rare indication have not been reported.